Studies analyzing the human disease condition cerebral cavernous malformations (CCM) also showed that increases in KLF2 mRNA levels can contribute to disease progression61, illustrating the need of a tight control of KLF2 expression. This evidence concerns the gene KLF2 and cerebral cavernous malformation.